[ad_1]
The $3.9 billion acquisition of Advanced Accelerator Applications would mark a rare deal in the pharmaceutical sector this year.
[ad_2]
Source link
This is from today’s news)
Novartis Looks to Buy French Firm to Bolster Cancer Portfolio
—
by